Perrigo's Calendar Reminder: Tomorrow We Learn If Self-Care Still Sells

Perrigo Company (PRGO) reports first-quarter 2026 earnings tomorrow, May 6, before market open, with analysts expecting a sharp year-over-year decline in profitability. The consumer healthcare company faces a critical test as investors assess whether recent operational challenges are temporary headwinds or signs of deeper structural pressure. With the stock trading 30% below its 200-day moving average and analyst estimates slashed dramatically, this report will determine whether PRGO can stabilize or faces further downside.

Part 1: Earnings Preview

Perrigo is a leading provider of over-the-counter healthcare products and generic pharmaceuticals, operating primarily in North America and Europe through its Consumer Self-Care Americas and International segments. The company's portfolio spans store-brand and branded offerings across categories including pain relief, gastrointestinal, nutrition, and skincare products.

Perrigo reports Q1 2026 results on May 6 before market open, with consensus expecting $0.39 per share on revenue estimates that remain unavailable in current data. The company most recently reported $0.77 per share for Q4 2025. Compared to the same quarter last year when PRGO earned $0.60 per share, the current estimate of $0.39 represents a 35% year-over-year decline—a dramatic reversal that has analysts questioning the company's near-term trajectory.

Three key themes define this earnings story:

Supply Chain and Margin Pressure: Investors are watching whether operational disruptions and input cost inflation continue to compress margins across both the Consumer Self-Care and pharmaceutical segments. The sharp estimate cuts suggest analysts expect these headwinds to persist through at least the first half of 2026.

Private Label Demand Dynamics: As a major supplier of store-brand products to retailers, Perrigo's performance reflects broader consumer behavior around value-seeking purchases. Any commentary on retailer inventory levels, promotional activity, or market share shifts in key categories will signal whether the company's core business model remains resilient.

Full-Year Guidance Reset: With full-year 2026 estimates now at $2.12 versus prior expectations of $2.75, management's updated outlook will be critical. Investors need clarity on whether the company sees a path back to growth in 2027 (currently projected at $2.38, up 12%) or if structural challenges require a longer recovery timeline.

Analyst commentary ahead of the release has turned cautious. The consensus has shifted from Hold toward Sell territory over the past month, with the Barchart Technical Opinion deteriorating from 88% Sell a month ago to 40% Sell currently—a modest improvement but still reflecting negative sentiment. With only one Strong Buy rating against four Hold ratings, the Street is clearly in wait-and-see mode, looking for evidence that management can execute a turnaround.

Part 2: Historical Earnings Performance

Perrigo's recent earnings history shows an inconsistent pattern of beats and misses, with no clear trend in either direction. Over the past four quarters, the company has delivered two beats and two misses against consensus estimates.

The most recent quarter (Q4 2025) saw PRGO report $0.77 versus estimates of $0.80, a miss of 3.75%. This followed a strong Q3 2025 performance where the company beat by 6.67% ($0.80 actual vs. $0.75 estimate). Earlier in 2025, Q2 brought a 3.39% miss ($0.57 vs. $0.59 expected), while Q1 delivered a solid 7.14% beat ($0.60 vs. $0.56 estimate).

The magnitude of surprises has been relatively modest, ranging from 3-7% in either direction, suggesting PRGO's results typically land close to expectations. However, the alternating pattern of beats and misses indicates execution volatility rather than consistent outperformance or underperformance. With estimates for the upcoming quarter down sharply year-over-year, investors will be watching whether management can at least meet the lowered bar or if further disappointment awaits.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Perrigo typically reports before market open, meaning Day 0 captures the first full trading session reaction to results, while Day +1 reflects follow-through momentum.

Historical price behavior around Perrigo earnings reveals significant volatility, with an average absolute Day 0 move of 8.48% and Day +1 move of 5.20%. The most dramatic reaction came in November 2025, when the stock plunged 25.21% on earnings day following Q3 results, despite the company actually beating estimates. This suggests the market reacted negatively to guidance or underlying business trends rather than the headline number.

The direction of moves has been mixed but skewed negative in recent reports. The February 2026 report (most recent) saw a modest 1.53% decline on Day 0 followed by a sharper 6.84% drop on Day +1, indicating deteriorating sentiment after investors digested the details. August 2025 showed a similar pattern with an initial 11.31% decline on Day 0.

Notably, intraday volatility (Day 0 Range) averages 8.48%, matching the average absolute move, while Day +1 ranges average 5.95%. This suggests the initial reaction tends to be decisive, with follow-through sessions showing continued but diminished volatility. Given the sharp estimate cuts heading into tomorrow's report, investors should prepare for potential double-digit percentage swings in either direction depending on whether results and guidance surprise relative to the already-lowered expectations.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 13.80% (±$1.61) for the May 15 expiration, significantly higher than the 8.48% average historical Day 0 move. This elevated implied volatility of 98.02% suggests options traders are anticipating a larger-than-typical reaction to tomorrow's earnings, likely reflecting heightened uncertainty around the magnitude of the earnings miss or beat and the tone of management's guidance reset.

Part 3: What Analysts Are Saying

Analyst sentiment on Perrigo reflects cautious positioning ahead of earnings, with the consensus rating at 3.40 (between Hold and Buy) based on five analysts. The breakdown shows 1 Strong Buy, 0 Moderate Buys, 4 Holds, 0 Moderate Sells, and 0 Strong Sells—a defensive stance that suggests most analysts are waiting for clearer evidence of stabilization before recommending accumulation.

The average price target sits at $16.00, with a tight range from $15.00 to $17.00. From the current price of $11.64, this implies 37% upside potential—a meaningful gap that indicates analysts believe the stock has been oversold relative to its fundamental value, even accounting for near-term headwinds.

Sentiment has improved over the past month, with the consensus shifting from a more negative posture. A month ago, the analyst mix included one Strong Sell rating that has since been removed, while one analyst upgraded from Hold to Strong Buy or another analyst moved from Sell to Hold. This modest improvement suggests some analysts see the sharp selloff as having created value, though the predominance of Hold ratings indicates most prefer to see execution before turning more constructive.

The 37% implied upside to the consensus target provides a cushion for patient investors, but the wide gap also reflects significant uncertainty about the path and timing of any recovery. Tomorrow's report and guidance will be critical in determining whether analysts maintain, raise, or cut their targets based on management's visibility into the second half of 2026 and beyond.

Part 4: Technical Picture

Perrigo's technical setup heading into earnings shows a stock attempting to stabilize after a prolonged downtrend, though the overall picture remains cautious. The Barchart Technical Opinion currently reads 40% Sell, an improvement from 56% Sell a week ago and 88% Sell a month ago. This gradual strengthening suggests some near-term stabilization, but the signal remains in negative territory.

Timeframe Analysis:

• Short-term (Hold): Neutral signal indicates the immediate trend has lost downward momentum and entered a consolidation phase
• Medium-term (50% Sell): Moderate sell signal reflects continued weakness in the intermediate timeframe, suggesting the recent bounce may be temporary
• Long-term (100% Sell): Strong sell signal confirms the dominant trend remains firmly negative, with the stock well below key long-term moving averages

Trend Characteristics: The combination of Soft strength and Weakest direction indicates a weak, deteriorating trend environment—the stock is attempting to find a floor but lacks conviction or momentum heading into the earnings catalyst.

The stock trades at $11.64, positioned above its 5-day ($11.62), 10-day ($11.64), 20-day ($11.49), and 50-day ($11.05) moving averages, suggesting short-term momentum has turned positive. However, PRGO remains below both its 100-day average ($12.65) and 200-day average ($16.70), confirming the longer-term downtrend remains intact.

The 30% gap between the current price and the 200-day moving average illustrates the severity of the selloff, while the recent move above shorter-term averages suggests some technical stabilization. Key resistance likely sits at the 100-day moving average near $12.65, while support appears around the 50-day at $11.05. The technical setup is neither strongly supportive nor prohibitively cautious—the stock has stabilized enough to avoid signaling imminent further collapse, but lacks the momentum or trend structure to suggest a durable bottom is in place. Tomorrow's earnings will likely determine whether PRGO can build on recent stabilization and challenge resistance, or if renewed selling pressure sends the stock back toward testing support levels.